Stay updated on Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.

Latest updates to the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page
- Check2 days agoChange DetectedThe record presents details of a completed Phase 2 trial of pembrolizumab and interferon gamma-1b for mycosis fungoides, Sézary syndrome, and advanced synovial sarcoma. It also includes participant criteria, study outcomes, locations, results, and a study protocol document.SummaryDifference81%

- Check9 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA site-wide banner announces NIH website transition updates and says NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check23 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study record page displays a 403 Forbidden message and a Home link instead of study details.SummaryDifference0.5%

Stay in the know with updates to Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.